Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Intel Corporation (INTC) -- Ignore unavailable to you. Want to Upgrade?

To: willcousa who wrote (145409)	10/16/2001 10:28:25 AM
From: John Walliker	Respond to of 186894

willcousa, In any large scale innoculation program some people get the disease from the innoculation, so it is a two-edged sword. This is not true in general. Some older vaccines have used a weakened live organism, in which case this could happen. Most if not all modern vaccines use protein fragments from the surface of the organism to trigger the immune system. Because the whole pathological organism (virus, bacteria or parasite) is not present it is impossible to contract the disease from such vaccinations. There could, however, be allergic responses in rare cases. John